Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Cerence
CRNC
$385M
| $725K | ﹤0.01% |
67,839
+10,846
| +19% | +$119K |
|
3602
OneSpan
OSPN
$606M
| $722K | ﹤0.01% |
56,246
+5,411
| +11% | +$73.4K |
|
|
NXDR
3603
Nextdoor Holdings
NXDR
$990M
| $722K | ﹤0.01% |
343,896
+45,791
| +15% | +$89.8K |
|
|
KREF
3604
KKR Real Estate Finance Trust
KREF
$496M
| $721K | ﹤0.01% |
87,750
+5,635
| +7% | +$47.7K |
|
3605
Natural Gas Services Group
NGS
$472M
| $720K | ﹤0.01% |
21,384
+6,640
| +45% | +$198K |
|
3606
Vishay Precision Group
VPG
$938M
| $718K | ﹤0.01% |
18,654
+1,495
| +9% | +$52.9K |
|
3607
York Water
YORW
$534M
| $718K | ﹤0.01% |
22,544
+2,212
| +11% | +$70.8K |
|
3608
ARKO Corp
ARKO
$505M
| $716K | ﹤0.01% |
157,714
+18,285
| +13% | +$82K |
|
3609
Information Services Group
III
$242M
| $715K | ﹤0.01% |
123,735
+5,071
| +4% | +$28.5K |
|
3610
Sierra Bancorp
BSRR
$532M
| $715K | ﹤0.01% |
21,880
-609
| -3% | -$18.4K |
|
3611
LSB Industries
LXU
$709M
| $714K | ﹤0.01% |
83,950
+8,136
| +11% | +$71.8K |
|
|
KRMN
3612
Karman Holdings
KRMN
$7.89B
| $712K | ﹤0.01% |
9,733
-3,231
| -25% | -$234K |
|
3613
STRATTEC Security
STRT
$341M
| $710K | ﹤0.01% |
9,330
+1,168
| +14% | +$83.6K |
|
|
PPLT
3614
abrdn Physical Platinum Shares ETF
PPLT
$2.01B
| $709K | ﹤0.01% |
38,040
+36,170
| +1,934% | +$557K |
|
3615
AdvanSix
ASIX
$441M
| $708K | ﹤0.01% |
40,919
+3,365
| +9% | +$58.8K |
|
|
RERE
3616
ATRenew
RERE
$1.03B
| $707K | ﹤0.01% |
133,475
-5,833
| -4% | -$26.1K |
|
3617
Peoples Financial Services
PFIS
$716M
| $707K | ﹤0.01% |
14,507
+373
| +3% | +$18K |
|
|
OPTU
3618
Optimum Communications Inc
OPTU
$230M
| $705K | ﹤0.01% |
427,382
+52,557
| +14% | +$107K |
|
3619
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $704K | ﹤0.01% |
+7,700
| New | +$705K |
|
3620
Humacyte
HUMA
$165M
| $701K | ﹤0.01% |
729,469
+546,491
| +299% | +$774K |
|
|
CHCT
3621
Community Healthcare Trust
CHCT
$438M
| $700K | ﹤0.01% |
42,646
+4,105
| +11% | +$61.3K |
|
3622
Silvercrest Asset Management
SAMG
$79.3M
| $697K | ﹤0.01% |
45,889
-2,584
| -5% | -$37.5K |
|
|
DHIL
3623
DELISTED
Diamond Hill
DHIL
| $696K | ﹤0.01% |
4,105
-52
| -1% | -$7.2K |
|
3624
8x8 Inc
EGHT
$289M
| $695K | ﹤0.01% |
352,744
+75,636
| +27% | +$149K |
|
3625
Amplify Cybersecurity ETF
HACK
$3.01B
| $695K | ﹤0.01% |
8,646
+3,190
| +58% | +$271K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.